F506-0593 Screening compound: N-(3,4-dimethylphenyl)-3-{3-[2-(4-fluorophenyl)-4-methyl-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl]-1,2,4-oxadiazol-5-yl}propanamide

F506-0593 Screening compound: N-(3,4-dimethylphenyl)-3-{3-[2-(4-fluorophenyl)-4-methyl-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl]-1,2,4-oxadiazol-5-yl}propanamide
F506-0593 Screening compound: N-(3,4-dimethylphenyl)-3-{3-[2-(4-fluorophenyl)-4-methyl-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl]-1,2,4-oxadiazol-5-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F506-0593
N-(3,4-dimethylphenyl)-3-{3-[2-(4-fluorophenyl)-4-methyl-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl]-1,2,4-oxadiazol-5-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F506-0593

Molecular Formula

C23H21FN6O4 (C23 H21 FN6 O4)

Compound Name

N-(3,4-dimethylphenyl)-3-{3-[2-(4-fluorophenyl)-4-methyl-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl]-1,2,4-oxadiazol-5-yl}propanamide

IUPAC name

N-(34-dimethylphenyl)-3-{3-[2-(4-fluorophenyl)-4-methyl-35-dioxo-2345-tetrahydro-124-triazin-6-yl]-124-oxadiazol-5-yl}propanamide

SMILES

Cc(cc1)c(C)cc1NC(CCc1nc(C(C(N2C)=O)=NN(c(cc3)ccc3F)C2=O)no1)=O

InChI

InChI=1S/C23H21FN6O4/c1-13-4-7-16(12-14(13)2)25-18(31)10-11-19-26-21(28-34-19)20-22(32)29(3)23(33)30(27-20)17-8-5-15(24)6-9-17/h4-9,12H,10-11H2,1-3H3,(H,25,31)

InChI Key

YHMISUIPRPYGEK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27134487

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.46

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.802

Distribution Coefficient, logD

3.802

Water Solubility, LogSw

-3.88

Polar Surface Area

96.503

Acid Dissociation Constant (pKa)

12.58

Base Dissociation Constant (pKb)

2.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

F506-0593 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Immune system
  • animal

References: we are preparing a list of scientific research reports with F506-0593 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F506-0593?
Check Price and Availability of F506-0593, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F506-0593 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F506-0593
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F506-0593
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F506-0593 available by request